ImaraCompany Details

Get alertedif Imara gets funded!
Company description

Imara is dedicated to developing novel therapeutics for patients with sickle cell disease, a rare, genetic blood disease that leads to a reduction of healthy red blood cells, blocked blood vessels and a multitude of pathologies.

 

Funding history

Key people
Christoph AdamsDirector, Executive Officer
Mette AggerDirector
Barbara DaltonDirector
Robert HopfnerDirector
James McArthurDirector, Executive Officer
David MottDirector
Sara NayeemDirector
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!